Immunodeficiency common variable and Allergic rhinitis

Summary:

Allergic rhinitis is found among people with Immunodeficiency common variable, especially for people who are female, 60+ old.

The study analyzes which people have Allergic rhinitis with Immunodeficiency common variable. It is created by eHealthMe based on reports of 13 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Immunodeficiency common variable?

Immunodeficiency common variable is found to be associated with 86 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.

What is Allergic rhinitis?

Allergic rhinitis is found to be associated with 906 drugs and 1,317 conditions by eHealthMe. Check the latest studies of Allergic rhinitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

13 people who have Immunodeficiency Common Variable and Allergic Rhinitis are studied.

Would you have Allergic rhinitis when you have Immunodeficiency common variable?

Gender of people who have Immunodeficiency Common Variable and experienced Allergic Rhinitis *:

female: 92.31 %
male: 7.69 %

Age of people who have Immunodeficiency Common Variable and experienced Allergic Rhinitis *:

Common co-existing conditions for these people *:

Primary Immunodeficiency Syndrome: 10 people, 76.92%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.69%
Asthma: 1 person, 7.69%

Common drugs taken by these people *:

Crestor: 11 people, 84.62%
Epinephrine: 11 people, 84.62%
Lidocaine: 10 people, 76.92%
Acetaminophen: 10 people, 76.92%
Metformin Hydrochloride: 9 people, 69.23%
Zetia: 7 people, 53.85%
Aspirin: 6 people, 46.15%
Actemra: 6 people, 46.15%
Linzess: 6 people, 46.15%
Flaxseed: 6 people, 46.15%

Common symptoms for these people *:

Infusion Site Swelling: 10 people, 76.92%
Infection: 7 people, 53.85%
Sinusitis (inflammation of sinus): 6 people, 46.15%
Movement - Uncoordinated: 6 people, 46.15%
Injection Site Bruising: 6 people, 46.15%
Neuropathy Peripheral (surface nerve damage): 6 people, 46.15%
Infusion Site Pain: 6 people, 46.15%
Otitis (ear infection): 6 people, 46.15%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 6 people, 46.15%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 6 people, 46.15%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Allergic rhinitis?

- Check whether Allergic rhinitis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Immunodeficiency common variable (31,613 reports)
Allergic rhinitis (20,443 reports)

All the drugs that are associated with Allergic rhinitis:

Allergic rhinitis (906 drugs)

All the conditions that are associated with Allergic rhinitis:

Allergic rhinitis (1,317 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Allergic rhinitis and Immunodeficiency common variable, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.